CareDx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CareDx and other ETFs, options, and stocks.

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. 

CEO
John W. Hanna
CEOJohn W. Hanna
Employees
765
Employees765
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1998
Founded1998
Employees
765
Employees765

CDNA Key Statistics

Market cap
1.07B
Market cap1.07B
Price-Earnings ratio
-136.02
Price-Earnings ratio-136.02
Dividend yield
Dividend yield
Average volume
792.42K
Average volume792.42K
High today
$21.29
High today$21.29
Low today
$20.39
Low today$20.39
Open price
$21.21
Open price$21.21
Volume
196.59K
Volume196.59K
52 Week high
$23.24
52 Week high$23.24
52 Week low
$10.96
52 Week low$10.96

Stock Snapshot

As of today, CareDx(CDNA) shares are valued at $20.77. The company's market cap stands at 1.07B, with a P/E ratio of -136.02.

On 2026-05-05, CareDx(CDNA) stock traded between a low of $20.39 and a high of $21.29. Shares are currently priced at $20.77, which is +1.9% above the low and -2.4% below the high.

The CareDx(CDNA)'s current trading volume is 196.59K, compared to an average daily volume of 792.42K.

During the past year, CareDx(CDNA) stock moved between $10.96 at its lowest and $23.24 at its peak.

During the past year, CareDx(CDNA) stock moved between $10.96 at its lowest and $23.24 at its peak.

CDNA News

TipRanks 6d
CareDx price target raised to $28 from $26 at BTIG

BTIG raised the firm’s price target on CareDx (CDNA) to $28 from $26 and keeps a Buy rating on the shares. The company has announced many positive updates on it...

TipRanks 7d
CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones

The Transplant Company announced it has entered into a definitive agreement to acquire Naveris. The transaction is an extension of CareDx’s (CDNA) strategy to f...

TipRanks 7d
CareDx to Acquire Naveris, Expanding Oncology Diagnostics

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own CDNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.